Xylem (XYL)
(Delayed Data from NYSE)
$119.46 USD
-2.32 (-1.91%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $119.45 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$119.46 USD
-2.32 (-1.91%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $119.45 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Zacks News
Xylem (XYL) Exhibits Strong Prospects, Headwinds Remain
by Zacks Equity Research
Xylem (XYL) is poised to gain from strength in its businesses, solid backlog level and shareholder-friendly policies. High costs and expenses, along with supply-chain challenges, weigh on it.
Xylem (XYL) Q1 Earnings Top Estimates, Supply Woes Hurt
by Zacks Equity Research
Xylem's (XYL) Q1 earnings reflect the impacts of the weak Measurement & Control Solutions segment and supply-chain woes.
Xylem (XYL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 11.90% and 3.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem's (XYL) Q1 earnings are likely to have benefited from strength across its businesses. Supply-chain challenges and cost inflation might have been spoilsports.
Chart Industries (GTLS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Chart Industries (GTLS) delivered earnings and revenue surprises of 8.77% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Xylem (XYL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Tops Q4 Earnings Estimates, Hurt by Supply Woes
by Zacks Equity Research
Xylem's (XYL) Q4 earnings reflect the impacts of the weak Measurement & Control Solutions segment and supply-chain woes. It expects 1H22 performance to suffer from supply woes.
Xylem (XYL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 1.61% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
IDEX (IEX) Lags on Q4 Earnings, Projects Y/Y Growth for 2022
by Zacks Equity Research
IDEX's (IEX) Q4 earnings reflect the impacts of strength in segmental businesses and synergies from acquired assets. It predicts year-over-year growth in earnings per share for 2022.
Stanley Black (SWK) Q4 Earnings Beat, Down Y/Y on Supply Woes
by Zacks Equity Research
Stanley Black's (SWK) Q4 earnings reflect the impacts of buyout synergies, favorable pricing, lower volumes and cost inflation. It predicts year-over-year growth in earnings per share for 2022.
Will High Demand & Supply Woes Impact Xylem's (XYL) Q4 Earnings?
by Zacks Equity Research
Xylem's (XYL) Q4 results are likely to reflect gains from strengthening demand in end markets and operational execution. Inflationary pressure and supply-chain restrictions might have weighed on it.
Graco (GGG) Beats on Q4 Earnings & Sales, Faces Cost Woes
by Zacks Equity Research
Graco's (GGG) Q4 earnings reflect gains from solid segmental and regional results. Cost inflation and supply-chain woes impact margins. It projects organic sales growth for 2022.
Earnings Preview: Xylem (XYL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) & Isle to Lower Carbon Footprint in Water Systems
by Zacks Equity Research
Xylem's (XYL) partnership with Isle Utilities will help the technology innovators and water utilities execute advanced technology deployments in water systems.
Xylem (XYL) Exhibits Strong Prospects, Headwinds Persist
by Zacks Equity Research
Xylem (XYL) stands to gain from solid demand for its products, focus on innovation, healthy backlog level and shareholder-friendly policies. Rising costs and expenses and high debt level are concerns.
Why Is Xylem (XYL) Down 5.6% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Surpasses Q3 Earnings Estimates, Lowers View
by Zacks Equity Research
Xylem's (XYL) Q3 earnings reflect the impacts of healthy demand in Water Infrastructure and Applied Water segments as well as supply-chain woes. It lowers its 2021 projections.
Xylem (XYL) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 6.78% and -1.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Supply-Chain, Cost Woes to Influence Xylem's (XYL) Q3 Earnings
by Zacks Equity Research
Xylem's (XYL) Q3 results are likely to reflect the impacts of restricted availability of electronic components and cost inflation. Contract wins, product offerings and end markets are likely to have aided.
Earnings Preview: Xylem (XYL) Q3 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) and Dragos to Provide Cybersecurity Solutions
by Zacks Equity Research
Xylem's (XYL) partnership with Dragos will enable it to offer co-branded incident response and incident prevention services to customers in the water utility sector.
Xylem (XYL) Provides Long-Term View, Updates '21 Projections
by Zacks Equity Research
Xylem (XYL) at the Analyst Day discusses long-term growth strategies and financial framework. For the second half of 2021, it expects $100 million of adverse sales impacts from supply-chain headwinds.
MNTX or XYL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MNTX vs. XYL: Which Stock Is the Better Value Option?
Why Is Xylem (XYL) Up 7.8% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MNTX vs. XYL: Which Stock Is the Better Value Option?
by Zacks Equity Research
MNTX vs. XYL: Which Stock Is the Better Value Option?